List view
An open source data science conference. Where data scientists go to learn, connect, spark innovation, and impact positive change. ## [R/Phamra In-Person Summit](https://rinpharma.com/post/2024-03-25-announcement/) > R/Pharma is excited to announce that we are partnering again with Posit PBC to host our in-person program at posit::conf(2024), happening at the Hyatt Regency Seattle. The Summit will be on Sunday Aug 11th 2024. The Summit can be booked via the posit::conf(2024) registration page below: > > https://reg.conf.posit.co/flow/posit/positconf24/reg/login > > The Summit can be booked independently of posit::conf(2024), or bundled with a posit::conf(2024) ticket, workshop or both. > > The R/Pharma Summit will focus on the future of drug development using open source. During the Summit, facilitators will foster in-person discussions and conversations about key items (reproducibility, submissions, scalability, etc.) with industry leaders about open-source tools for next-generation submissions. The day will start with a pharma workshop and then transition to interactive talks and discussions around open source drug development topics relevant to participating attendees. You can find a sample agenda for the R/Pharma Roundtable Summit here: > > https://rinpharma.github.io/positconf-roundtables-2024/ ## [Posit Announcement](https://posit.co/blog/posit-conf-2024-announcement/) > Posit::conf(2024) is one day of workshops, two days of conference keynotes and talks, and is the ultimate hub for mastering data science and creating connections in the open source community. Registration for in-person tickets is now open, happening August 12-14 in Seattle, WA! Visit [pos.it/conf](http://pos.it/conf) for additional information, including details on how to register. Registration for virtual attendees will open at a later date.
Overdue by 1 year(s)•Due by August 11, 2024•8/10 issues closed- No due date•6/6 issues closed
90min R Validation Hub session at R/Pharma summit at posit::conf
Overdue by 2 year(s)•Due by September 18, 2023•1/1 issues closed